These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 821757)
1. Solubilization of histocompatibility and tumour-associated antigens of the P-815 murine mastocytoma cell. Clemetson KJ; Gerber A; Bertschmann M; Lüscher EF Eur J Cancer (1965); 1976 Apr; 12(4):263-70. PubMed ID: 821757 [No Abstract] [Full Text] [Related]
2. Water-soluble P-815 mastocytoma membrane antigens: separation of tumour-associated antigens from histocompatibility antigens. Clemetson KJ; Bertschmann M; Widmer S; Lüscher EF Immunochemistry; 1976 May; 13(5):383-8. PubMed ID: 820631 [No Abstract] [Full Text] [Related]
3. Preparation and properties of antisera directed against antigens of the P-815 mastocytoma cell not shared by its syngeneic host, the DBA/2 mouse. Bertschmann M; Clemetson KJ; Lüscher EF Eur J Cancer (1965); 1976 Apr; 12(4):255-62. PubMed ID: 60238 [No Abstract] [Full Text] [Related]
4. Antigenic changes of DBA/2J mastocytoma cells when grown in the BALB/c mouse. Wolf JE; Faanes RB; Choi YS J Natl Cancer Inst; 1977 May; 58(5):1407-12. PubMed ID: 67213 [TBL] [Abstract][Full Text] [Related]
5. The blocking activity of antisera raised to either tumor antigens or alloantigens in cytotoxicity assays using syngeneic or allogeneic killer cells on the P815 murine mastocytoma target. Al-Rammahy AK; Levy JG Cell Immunol; 1980 Dec; 56(2):338-46. PubMed ID: 6781763 [No Abstract] [Full Text] [Related]
6. The effect of capping H-2 antigens on the susceptibility of target cells to humoral and T cell-mediated lysis. Ekidin M; Henney CS Nat New Biol; 1973 Nov; 246(150):47-9. PubMed ID: 4202329 [No Abstract] [Full Text] [Related]
7. Isolation and partial characterization of a tumor-associated antigen of the P815 mastocytoma of DBA/2 mice. Al-Rammahy AK; Levy JG; Jackson AL J Immunol; 1980 Jan; 124(1):143-50. PubMed ID: 6765966 [No Abstract] [Full Text] [Related]
8. Cytotoxicity inhibition studies using 3 M KCl solubilized murine histocompatibility antigens and a new multiple automated sample harvester. Ahmed A; Thurman GB; Vannier WE; Sell KW; Strong DM J Immunol Methods; 1973 Aug; 3(1):1-16. PubMed ID: 4765855 [No Abstract] [Full Text] [Related]
9. Cytotoxicity inhibition studies using 3 M KC1 solubilized murine histocompatibility antigens and a new multiple automated sample harvester. Ahmed A; Thurman GB; Vannier WE; Sell KW; Strong DM J Immunol Methods; 1973 Aug; 3(1):1-16. PubMed ID: 4732342 [No Abstract] [Full Text] [Related]
10. Regulation of the immune response. VIII. Characteristics of antibody-mediated suppression of an in vitro cell-mediated immune response. Sinclair NR; Lees RK; Fagan G; Birnbaum A Cell Immunol; 1975 Apr; 16(2):330-47. PubMed ID: 803878 [No Abstract] [Full Text] [Related]
11. Surface H-2 antigen concentration requirement of somatic hybrid cells for IgM-mediated cytotoxicity. Rubio N Nature; 1974 May; 249(456):461-3. PubMed ID: 4134883 [No Abstract] [Full Text] [Related]
12. The genetic control of T cell-mediated immunity against the DBA/2 mastocytoma P-815. II. Low responsiveness in T cell-mediated cytotoxicity accompanied by the inability to produce antibodies in a secondary response. Kölsch E Eur J Immunol; 1975 Aug; 5(8):527-32. PubMed ID: 824139 [TBL] [Abstract][Full Text] [Related]
13. Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice. Fujimoto S; Chen CH; Sabbadini E; Sehon AH J Immunol; 1973 Oct; 111(4):1093-100. PubMed ID: 4728678 [No Abstract] [Full Text] [Related]
14. Tumour-associated antigens of the mouse P-815 mastocytoma cell: evidence for an antigen with H-2-like characteristics. Clemetson KJ; Bertschmann M; Lüscher EF Mol Immunol; 1981 Feb; 18(2):135-41. PubMed ID: 6167852 [No Abstract] [Full Text] [Related]
15. Effect of antigen density on complement-mediated lysis, T-cell-mediated killing, and antigenic modulation. Lesley J; Hyman R; Dennert G J Natl Cancer Inst; 1974 Dec; 53(6):1759-65. PubMed ID: 4140238 [No Abstract] [Full Text] [Related]
16. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect. Igarashi T; Okada M; Kishimoto S; Yamamura Y Immunology; 1975 Jan; 28(1):37-47. PubMed ID: 803916 [TBL] [Abstract][Full Text] [Related]
17. Discussion paper: the immune status of the murine host bearing transplantable syngeneic growing tumors. Manson LA Ann N Y Acad Sci; 1976; 276():272-5. PubMed ID: 829206 [No Abstract] [Full Text] [Related]
18. The existence of antibody-like activities against the weakly immunogenic minor histocompatibility antigens. Faanes RB; Wolf JE; Chiu KM; Choi YS Cell Immunol; 1980 May; 51(2):262-72. PubMed ID: 6768458 [No Abstract] [Full Text] [Related]
19. Antibody mediated neutralization of immunosuppression induced by mastocytoma ascites fluids. Watanabe M; Pan S; Friedman H Proc Soc Exp Biol Med; 1978 Jun; 158(2):238-41. PubMed ID: 79184 [No Abstract] [Full Text] [Related]
20. H-2 histocompatibility alloantigens. Some biochemical properties of the molecules solubilized by NP-40 detergent. Schwartz BD; Kato K; Cullen SE; Nathenson SG Biochemistry; 1973 May; 12(11):2157-64. PubMed ID: 4196220 [No Abstract] [Full Text] [Related] [Next] [New Search]